Key Financial Data Of Group

K Pharma,Inc. - Filing #7311570

Concept As at
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-06-30
2023-01-01 to
2023-06-30
Key financial data of group
Business results of group
Net sales
JPY
1,000,000,000 JPY
1,000,000,000 JPY
Ordinary profit (loss)
-422,670,000 JPY
344,184,000 JPY
651,026,000 JPY
Net assets
2,678,263,000 JPY
3,104,768,000 JPY
1,851,036,000 JPY
Total assets
2,789,266,000 JPY
3,313,902,000 JPY
2,225,630,000 JPY
Basic earnings (loss) per share
-36.75
25.42
52.11
Diluted earnings per share
23.07
Equity-to-asset ratio
0.960 xbrli:pure
0.937 xbrli:pure
0.832 xbrli:pure
Net cash provided by (used in) operating activities
-562,445,000 JPY
454,425,000 JPY
848,528,000 JPY
Net cash provided by (used in) investing activities
-9,306,000 JPY
-11,099,000 JPY
-9,781,000 JPY
Net cash provided by (used in) financing activities
JPY
1,486,235,000 JPY
-90,000 JPY
Cash and cash equivalents
2,694,656,000 JPY
3,266,408,000 JPY
2,175,504,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.